Literature DB >> 16387943

Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension.

S Provencher1, D Chemla, P Hervé, O Sitbon, M Humbert, G Simonneau.   

Abstract

Patients with pulmonary arterial hypertension (PAH) exhibit a limited increase in stroke volume on exercise, and the heart rate (HR) increases may reflect the main mechanism that allows cardiac output to increase. The current prospective study documented the contribution of HR to the 6-min walking distance (6MWD) in idiopathic (IPAH) and nonidiopathic PAH. Eighty-three patients (46 IPAH and 37 nonidiopathic PAH) underwent haemodynamic evaluation and a 6MWD test. Chronotropic response (peak walking HR minus resting HR) and peripheral oxygen saturation were monitored. Fifty-seven patients were also assessed after 5+/-2 months of treatment (bosentan n = 38, epoprostenol n = 14, bosentan-epoprostenol n = 3, iloprost n = 2). Before treatment, the 6MWD was related to numerous demographic, haemodynamic and walking test characteristics. Stepwise regression analysis indicated that the only factors significantly associated with the 6MWD were stroke volume and chronotropic response in both IPAH and nonidiopathic PAH patients. Following treatment, changes in 6MWD were significantly related to changes in chronotropic response in both IPAH and nonidiopathic PAH. In conclusion, baseline stroke volume and chronotropic response were independently associated with the 6-min walking distance in pulmonary arterial hypertension. The lack of chronotropic response may reflect the loss in normal physiological reserve in more unwell patients.

Entities:  

Mesh:

Year:  2006        PMID: 16387943     DOI: 10.1183/09031936.06.00042705

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  28 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 2.  Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Authors:  Jennifer L Snow; Steven M Kawut
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

3.  Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension.

Authors:  Simon Malenfant; François Potus; Frédéric Fournier; Sandra Breuils-Bonnet; Aude Pflieger; Sylvie Bourassa; Ève Tremblay; Benjamin Nehmé; Arnaud Droit; Sébastien Bonnet; Steeve Provencher
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

4.  Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.

Authors:  Adriano R Tonelli; Laith Alkukhun; Vineesha Arelli; José Ramos; Jennie Newman; Kevin McCarthy; Bohdan Pichurko; Omar A Minai; Raed A Dweik
Journal:  Clin Transl Sci       Date:  2013-09-06       Impact factor: 4.689

5.  Step climbing capacity in patients with pulmonary hypertension.

Authors:  Benjamin Daniel Fox; David Langleben; Andrew Hirsch; Kim Boutet; Avi Shimony
Journal:  Clin Res Cardiol       Date:  2012-08-09       Impact factor: 5.460

6.  Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Amy L Olson; Oksana A Shlobin; Shahzad Ahmad; Kevin K Brown; Steven D Nathan
Journal:  Respirology       Date:  2011-04       Impact factor: 6.424

7.  Assessment of daily life physical activities in pulmonary arterial hypertension.

Authors:  Vincent Mainguy; Steeve Provencher; François Maltais; Simon Malenfant; Didier Saey
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  Exercise intolerance in pulmonary arterial hypertension.

Authors:  Robin M Fowler; Kevin R Gain; Eli Gabbay
Journal:  Pulm Med       Date:  2012-06-10

Review 9.  High Right Ventricular Afterload during Exercise in Patients with Pulmonary Arterial Hypertension.

Authors:  Mari Nishizaki; Aiko Ogawa; Hiromi Matsubara
Journal:  J Clin Med       Date:  2021-05-09       Impact factor: 4.241

10.  A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study.

Authors:  Florian F Hildenbrand; Ivan Fauchère; Lars C Huber; Stephan Keusch; Rudolf Speich; Silvia Ulrich
Journal:  Respir Res       Date:  2012-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.